Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Y Ojima
Prognostic Factors for Visual Outcomes 2-Years After Intravitreal Bevacizumab for Myopic Choroidal Neovascularization
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Related publications
Intravitreal Bevacizumab for Choroidal Neovascularization Secondary to Angioid Streaks
Archives of Ophthalmology
Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization Associated With Pattern Dystrophy
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Subfoveal Choroidal Thickness Changes After Intravitreal Bevacizumab Therapy for Central Serous Chorioretinopathy
Arquivos Brasileiros de Oftalmologia
Medicine
Ophthalmology
Visual Acuity Outcomes of Ranibizumab Treatment in Pathologic Myopic Eyes With Macular Retinoschisis and Choroidal Neovascularization
Retina
Medicine
Ophthalmology
Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Angioid Streaks in a Non-Responder to Intravitreal Ranibizumab
International Medical Case Reports Journal
Medicine
Reply To: Effect of Axial Length on Myopic Choroidal Neovascularization
Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Long-Term Results of Intravitreal Bevacizumab and Dexamethasone for the Treatment of Punctate Inner Choroidopathy Associated With Choroidal Neovascularization: A Case Series
SAGE Open Medical Case Reports
Suppression of Choroidal Neovascularization by Intravitreal Injection of Liposomal SU5416
Archives of Ophthalmology
Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
